Women's Preventive Services Guidelines
Applicable as of December 29, 2017, HRSA updated the HRSA- supported Women's Preventive Services Guidelines for purposes of health insurance coverage for preventive services that address health needs specific to women based on clinical recommendations from the Women's Preventive Services Initiative. This 2017 update adds two additional servicesScreening for Diabetes Mellitus after Pregnancy and Screening for Urinary Incontinenceto the nine preventive services included in the 2016 update to the HRSA-supported Women's Preventive Services Guidelines. The nine services included in the 2016 update are as follows: Breast Cancer Screening for Average Risk Women, Breastfeeding Services and Supplies, Screening for Cervical Cancer, Contraception, Screening for Gestational Diabetes Mellitus, Screening for Human Immunodeficiency Virus Infection, Screening for Interpersonal and Domestic Violence, Counseling for Sexually Transmitted Infections, and Well-Woman Preventive Visits. This notice serves as an announcement of the decision to update the guidelines as listed below. Please see https://www.hrsa.gov/womens-guidelines/index.html for additional information.
Advisory Commission on Childhood Vaccines
In accordance with the Federal Advisory Committee Act, notice is hereby given that a meeting is scheduled for the Advisory Commission on Childhood Vaccines (ACCV). This meeting will be open to the public. Information about the ACCV and the agenda for this meeting can be obtained by accessing the following website: http://www.hrsa.gov/ advisorycommittees/childhoodvaccines/index.html.
Advisory Committee on Heritable Disorders in Newborns and Children
This notice announces a correction to the meeting announcement for a public meeting of the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC), published in the Federal Register on January 22, 2018. The meeting has changed from a two-day meeting to a one-day meeting, to be held on Thursday, February 8, 2018. Agenda items have been updated and will include a final evidence-based review report on the spinal muscular atrophy (SMA) condition nomination for possible inclusion on the Recommended Uniform Screening Panel (RUSP). Following this report, the ACHDNC expects to vote on whether to recommend adding SMA to the RUSP to the Secretary of HHS. The agenda will also include presentation of a document on cutoff determinations and risk assessment methods used for dried bloodspot newborn screening. The Committee expects to vote on whether to support this document. The ACHDNC members will also consider a report on Quality Measures in Newborn Screening from the Follow up and Treatment Workgroup. HRSA will post the agenda two days prior to the meeting on the Committee's website: https:// www.hrsa.gov/advisory-committees/heritable-disorders/index.ht ml. Please note that agenda items are subject to changes as priorities dictate.